Zusammenfassung
Diabetes mellitus ist der Sammelbegriff für verschiedene Stoffwechselstörungen, die mit einer chronischen Hyperglykämie und mit dem Risiko für Schäden und Funktionsstörungen verschiedener Organe, insbesondere der Augen, Nieren, Nerven, des Herzens und der Blutgefäße verbunden sind. Ursache ist entweder eine gestörte Insulinsekretion oder eine gestörte Insulinwirkung oder auch beides.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Diabetes Association, ADA (1997) Clinical practice recommendations 1997. Diabetes Care 20(Suppl 1): S1–S70
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553
DECODE study group (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371–375
Engelgau MM, Aubert RE, Thompson TJ, Herman WH (1995) Screening for NIDDM in nonpregnant adults. A review of principles, screening tests and recommendations. Diabetes Care 18:1606–1618
Gottsäter A, Landin-Olsson M, Fernlund P et al (1993) Beta-cell function in relation to islet cell antibodies during the first 2 years after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902–910
Greci LS, Kailasam M, Malkani S et al. (2003) Utility of HbA1c levels for diabetes case finding in hospitalized patients with Hyperglycemia. Diabetes Care 26:1064–1068
Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342:301–307
Kerner W, Fuchs C, Redaelli M et al (2001) Definition, Klassifikation und Diagnostik des Diabetes mellitus. In: Scherbaum WA, Lauterbach KW, Joost HG (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Aufl, Deutsche Diabetes-Gesellschaft
Lindström J, Tuomilehto J (2003) The Diabetes Risk Score, A practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731
Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth international Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2): B161–167
Seissler J, de Nonnaville JJ, Morgenthaler NG et al (1998) Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 41:891–897
Tuomi T, Carlsson, Li H et al (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157
Turner R, Stratton I, Horton V et al (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288–1293
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scherbaum, W.A., Waldhäusl, W. (2004). Diabetes mellitus: Klassifikation, Diagnostik und Screeningstrategien. In: Waldhäusl, W.K., Gries, F.A., Scherbaum, W.A. (eds) Diabetes in der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18571-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-18571-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62166-6
Online ISBN: 978-3-642-18571-7
eBook Packages: Springer Book Archive